Informatics can identify systemic sclerosis (SSc) patients at risk for scleroderma renal crisis

被引:9
|
作者
Redd, Doug [1 ,2 ,3 ,4 ]
Frech, Tracy M. [1 ,2 ,3 ]
Murtaugh, Maureen A. [1 ,2 ,3 ]
Rhiannon, Julia [5 ]
Zeng, Qing T. [1 ,2 ,3 ,4 ]
机构
[1] Vet Affair Med Ctr Salt Lake City Hlth Care Syst, Salt Lake City, UT USA
[2] Univ Utah, Sch Med, Dept Internal Med, Div Rheumatol, Salt Lake City, UT 84108 USA
[3] Vet Affair Med Ctr, Sat Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84108 USA
[5] Vet Affair Med Ctr Denver Hlth Care Syst, Denver, CO USA
基金
美国国家卫生研究院;
关键词
Informatics; Systemic sclerosis; Scleroderma; Renal crisis; Prednisone; Steroid; Blood pressure; Hypertension; Natural language processing; Management; DISEASE;
D O I
10.1016/j.compbiomed.2014.07.022
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Electronic medical records (EMR) provide an ideal opportunity for the detection, diagnosis, and management of systemic sclerosis (SSc) patients within the Veterans Health Administration (VHA). The objective of this project was to use informatics to identify potential SSc patients in the VHA that were on prednisone, in order to inform an outreach project to prevent scleroderma renal crisis (SRC). Methods: The electronic medical data for this study came from Veterans Informatics and Computing Infrastructure (VINCI). For natural language processing (NLP) analysis, a set of retrieval criteria was developed for documents expected to have a high correlation to SSc. The two annotators reviewed the ratings to assemble a single adjudicated set of ratings, from which a support vector machine (SVM) based document classifier was trained. Any patient having at least one document positively classified for SSc was considered positive for SSc and the use of prednisone >= 10 mg in the clinical document was reviewed to determine whether it was an active medication on the prescription list. Results: In the VHA, there were 4272 patients that have a diagnosis of SSc determined by the presence of an ICD-9 code. From these patients, 1118 patients (21%) had the use of prednisone >= 10 mg. Of these patients, 26 had a concurrent diagnosis of hypertension, thus these patients should not be on prednisone. By the use of natural language processing (NLP) an additional 16,522 patients were identified as possible SSc, highlighting that cases of SSc in the VHA may exist that are unidentified by ICD-9. A 10-fold cross validation of the classifier resulted in a precision (positive predictive value) of 0.814, recall (sensitivity) of 0.973, and f-measure of 0.873. Conclusions: Our study demonstrated that current clinical practice in the VHA includes the potentially dangerous use of prednisone for veterans with SSc. This present study also suggests there may be many undetected cases of SSc and NLP can successfully identify these patients. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:203 / 205
页数:3
相关论文
共 50 条
  • [41] SCLERODERMA RENAL CRISIS IN PROGRESSIVE SYSTEMIC-SCLEROSIS UNDER IMMUNOSUPPRESSIVE THERAPY
    LAAFF, H
    BALLE, C
    SCHON, S
    FREUDENBERG, N
    SCHOLLMEYER, P
    PETER, HH
    MEDIZINISCHE KLINIK, 1988, 83 (10) : 315 - 319
  • [42] Scleroderma hypertensive renal crisis among systemic sclerosis patients: A national emergency department database study
    Uddin, Mohammed
    Mir, Tanveer
    Surapaneni, Sarvani
    Mehar, Anupamdeep
    Dar, Tawseef
    Changal, Khalid
    Ullah, Waqas
    Lohia, Prateek
    Bhat, Zeenat
    Sheikh, Mujeeb
    Burket, Mark
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 53 : 228 - 235
  • [43] Prediction of scleroderma renal crisis in patients of SSc: insight from the CRDC cohort study
    Huang, Haochen
    Xu, Shihan
    Li, Hongbin
    Duan, Xinwang
    Hui, Min
    Zhou, Jiaxin
    Zhang, Ling-ling
    Li, Mengtao
    Zeng, Xiaofeng
    Xu, Dong
    RHEUMATOLOGY, 2025,
  • [44] Assessment of kidney involvement in systemic sclerosis: From scleroderma renal crisis to subclinical renal vasculopathy
    Gigante, Antonietta
    Leodori, Giorgia
    Pellicano, Chiara
    Villa, Annalisa
    Rosato, Edoardo
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (05): : 529 - 537
  • [45] Scleroderma renal crisis and renal involvement in systemic sclerosis (vol 12, pg 678, 2016)
    Woodworth, Thasia G.
    Suliman, Yossra A.
    Li, Wendi
    Furst, Daniel E.
    Clements, Philip
    NATURE REVIEWS NEPHROLOGY, 2018, 14 (02) : 138 - 138
  • [46] Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor
    Hesselstrand, R.
    Scheja, A.
    Wuttge, D. M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 (01) : 39 - 43
  • [47] ACE-INHIBITORS IN ARTERIAL HYPERTENSION IN SSC PATIENTS DISPLAY A RISK FACTOR FOR SCLERODERMA RENAL CRISIS - A EUSTAR ANALYSIS
    Adler, S.
    Varisco, P. A.
    Distler, O.
    Buetikofer, L.
    Kowal-Bielecka, O.
    Allanore, Y.
    Riemekasten, G.
    Villiger, P. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1110 - 1110
  • [48] SCLERODERMA RENAL CRISIS WITH MINIMAL SKIN INVOLVEMENT AND NO SEROLOGIC EVIDENCE OF SYSTEMIC-SCLEROSIS
    GONZALEZ, EA
    SCHMULBACH, E
    BASTANI, B
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) : 317 - 319
  • [49] Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
    Okroj, Marcin
    Johansson, Martin
    Saxne, Tore
    Blom, Anna M.
    Hesselstrand, Roger
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [50] Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis
    Koichi Yanaba
    Yoshihide Asano
    Yayoi Tada
    Makoto Sugaya
    Takafumi Kadono
    Yasuhito Hamaguchi
    Shinichi Sato
    Clinical Rheumatology, 2012, 31 : 835 - 839